These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34270351)

  • 21. Diabetes Telehealth Solutions: Improving Self-Management Through Remote Initiation of Continuous Glucose Monitoring.
    Gal RL; Cohen NJ; Kruger D; Beck RW; Bergenstal RM; Calhoun P; Cushman T; Haban A; Hood K; Johnson ML; McArthur T; Olson BA; Weinstock RS; Oser SM; Oser TK; Bugielski B; Strayer H; Aleppo G
    J Endocr Soc; 2020 Sep; 4(9):bvaa076. PubMed ID: 32864542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes.
    Wadwa RP; Laffel LM; Shah VN; Garg SK
    Diabetes Technol Ther; 2018 Jun; 20(6):395-402. PubMed ID: 29901421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycaemic control in the paediatric and young adult population with type 1 diabetes following a single telehealth visit - what have we learned from the COVID-19 lockdown?
    Rachmiel M; Lebenthal Y; Mazor-Aronovitch K; Brener A; Levek N; Levran N; Chorna E; Dekel M; Barash G; Landau Z; Pinhas-Hamiel O
    Acta Diabetol; 2021 Jun; 58(6):697-705. PubMed ID: 33511493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fear of hypoglycemia in children with type 1 diabetes and their parents: Effect of pump therapy and continuous glucose monitoring with option of low glucose suspend in the CGM TIME trial.
    Verbeeten KC; Perez Trejo ME; Tang K; Chan J; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Richardson C; Cooper T; Lawson ML;
    Pediatr Diabetes; 2021 Mar; 22(2):288-293. PubMed ID: 33179818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2018; 18(2):1-160. PubMed ID: 29541282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rate of Change of Premeal Glucose Measured by Continuous Glucose Monitoring Predicts Postmeal Glycemic Excursions in Patients With Type 1 Diabetes: Implications for Therapy.
    Majithia AR; Wiltschko AB; Zheng H; Walford GA; Nathan DM
    J Diabetes Sci Technol; 2018 Jan; 12(1):76-82. PubMed ID: 28868899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic.
    Predieri B; Leo F; Candia F; Lucaccioni L; Madeo SF; Pugliese M; Vivaccia V; Bruzzi P; Iughetti L
    Front Endocrinol (Lausanne); 2020; 11():595735. PubMed ID: 33424771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
    Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW
    Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Innovative, Paradigm-Shifting Lifestyle Intervention to Reduce Glucose Excursions With the Use of Continuous Glucose Monitoring to Educate, Motivate, and Activate Adults With Newly Diagnosed Type 2 Diabetes: Pilot Feasibility Study.
    Oser TK; Cucuzzella M; Stasinopoulos M; Moncrief M; McCall A; Cox DJ
    JMIR Diabetes; 2022 Feb; 7(1):e34465. PubMed ID: 35050857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Real-Time Continuous Glucose Monitoring Data Sharing on Quality of Life and Health Outcomes in Adults with Type 1 Diabetes.
    Polonsky WH; Fortmann AL
    Diabetes Technol Ther; 2021 Mar; 23(3):195-202. PubMed ID: 32991199
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting Technology in Underserved Adults With Type 1 Diabetes: Effect of Diabetes Practice Transformations on Improving Equity in CGM Prescribing Behaviors.
    Mathias P; Mahali LP; Agarwal S
    Diabetes Care; 2022 Oct; 45(10):2231-2237. PubMed ID: 36054022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerability and acceptability of real-time continuous glucose monitoring and its impact on diabetes management behaviours in individuals with Type 2 Diabetes - A pilot study.
    Taylor PJ; Thompson CH; Luscombe-Marsh ND; Wycherley TP; Wittert G; Brinkworth GD; Zajac I
    Diabetes Res Clin Pract; 2019 Sep; 155():107814. PubMed ID: 31421138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protocol for a Randomized, Crossover Trial to Decrease Time in Hypoglycemia by Combined Intervention of the Usage of Intermittent-Scanning Continuous Glucose Monitoring Device and the Structured Education Regarding its Usage: Effect of Intermittent-Scanning Continuous Glucose Monitoring to Glycemic Control Including Hypoglycemia and Quality of Life of Patients with Type 1 Diabetes Mellitus Study (ISCHIA Study).
    Suzuki S; Tone A; Murata T; Nishimura K; Miyamoto Y; Sakane N; Satoh-Asahara N; Toyoda M; Hirota Y; Matsuhisa M; Kuroda A; Kato K; Kouyama R; Miura J; Suganuma A; Tomita T; Noguchi M; Son C; Kasahara M; Ito Y; Kasama S; Hosoda K
    Tokai J Exp Clin Med; 2021 Jul; 46(2):59-68. PubMed ID: 34216477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ROUTE-T1D: A behavioral intervention to promote optimal continuous glucose monitor use among racially minoritized youth with type 1 diabetes: Design and development.
    Straton E; Bryant BL; Kang L; Wang C; Barber J; Perkins A; Gallant L; Marks B; Agarwal S; Majidi S; Monaghan M; Streisand R
    Contemp Clin Trials; 2024 May; 140():107493. PubMed ID: 38460913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CGM Benefits and Burdens: Two Brief Measures of Continuous Glucose Monitoring.
    Messer LH; Cook PF; Tanenbaum ML; Hanes S; Driscoll KA; Hood KK
    J Diabetes Sci Technol; 2019 Nov; 13(6):1135-1141. PubMed ID: 30854886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
    Jones LV; Ray A; Moy FM; Buckley BS
    Cochrane Database Syst Rev; 2019 May; 5(5):CD009613. PubMed ID: 31120549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reducing Emotional Distress for Childhood Hypoglycemia in Parents (REDCHiP): Protocol for a Randomized Clinical Trial to Test a Video-Based Telehealth Intervention.
    Patton SR; McConville A; Marker AM; Monzon AD; Driscoll KA; Clements MA
    JMIR Res Protoc; 2020 Aug; 9(8):e17877. PubMed ID: 32808936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.